Neuroleptic syndrome among patients receiving antipsychotic drugs-review

@inproceedings{Yuabova2015NeurolepticSA,
  title={Neuroleptic syndrome among patients receiving antipsychotic drugs-review},
  author={Marina Yuabova},
  year={2015}
}
Neuroleptic Malignant Syndrome is occasional but deadly reaction, which results from treatment with antipsychotic medications. Risk aspects include the following: dehydration, agitation, and history of neuroleptic malignant syndrome.  Despite the fact that Neuroleptic Malignant Syndrome has been described as adverse effect from treatment with antipsychotic medications, patients suffering with chemical imbalance of brain or mood disorders, especially when treated with lithium, fall in to higher… 

Figures from this paper

References

SHOWING 1-10 OF 28 REFERENCES

Neuroleptic malignant syndrome: a review.

A concise and comprehensive review of neuroleptic malignant syndrome is presented, written with the practitioner in mind, to provide information that will be useful in actual clinical settings.

Neuroleptic Malignant Syndrome

  • B. Berman
  • Medicine, Psychology
    The Neurohospitalist
  • 2011
Maintaining vigilant awareness of the clinical features of NMS to diagnose and treat the disorder early remains the most important strategy by which physicians can keep mortality rates low and improve patient outcomes.

Atypical Neuroleptic Malignant Syndrome: Diagnostic Controversies and Considerations

Clinicians should not prematurely exclude a diagnosis of NMS in cases where severe rigidity or hyperthermia is not initially apparent, and in patients receiving any antipsychotic, clinicians should carefully evaluate any features of N MS.

Neuroleptic Malignant Syndrome Versus Serotonin Syndrome: The Search for a Diagnostic Tool

It is proposed that laboratory findings that include dopamine and serotonin metabolites can be used as adjuncts to clinical and prescription histories in the diagnosis of NMS.

Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.

  • P. PerryCourtney A Wilborn
  • Medicine, Psychology
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
  • 2012
The clinical laboratory profile of elevations in creatine kinase, liver function tests, and white blood cell count, coupled with a low serum iron level, distinguishes NMS from SS among patients taking neuroleptic and serotonin agonist medications simultaneously.

Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature.

Clinicians utilizing antipsychotics in managing delirium or agitation are advised to be vigilant for NMS and further study is required to determine whether certain patient characteristics or medications present greater risk for this serious adverse event.

Is Risk of Neuroleptic Malignant Syndrome Increased in the Postpartum Period ?

A prospective study spanning 30 months between 1994 and 1996 in a university general hospital that is a referral center for a large geographic area of 2 southern states of India found that three patients had onset in the postpartum period of neuroleptic malignant syndrome.

Neuroleptic malignant syndrome in an adolescent with CYP2D6 deficiency

The case highlights the importance of therapeutic drug monitoring in identification and differentiation of drug-induced effects in psychiatric disorder to prevent NMS and its complications and genotyping of CYP2D6 might be considered in patients with symptoms suggestive of drug toxicity who are treated with neuroleptics metabolized via the CYP 2D6 pathway.

Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report

Olanzapine-induced metabolic complications and NMS were dramatically improved with cessation of the olanzapine treatment and initiation of supportive management including fluid therapy, hemodialysis, and intensive glycemic control using insulin.

Neuroleptic malignant syndrome

Neuroleptic malignant syndrome is difficult to distinguish from febrile catatonia and the diagnosis can often only be made through the clinical course.